Doege–Potter syndrome
Doege–Potter syndrome is a paraneoplastic syndrome in which hypoglycemia is associated with solitary fibrous tumors. The hypoglycemia is the result of the tumors producing insulin-like growth factor 2. The syndrome was first described in 1930, by Karl Walter Doege, a German-American physician and by Roy Pilling Potter, an American radiologist, working independently; the full term Doege–Potter syndrome was infrequently used until the publication of a 2000 article using the eponym.
DPS is rare, with a malignancy rate of 12–15%. Actual rates of hypoglycemia associated with a fibrous tumor are quite rare, and are linked to large tumors with high rates of mitosis. Removal of the tumor will normally resolve the symptoms.
Tumors causing DPS tend to be quite large; in one case a, mass was removed, sufficiently large to cause a collapsed lung. In X-rays, they appear as a single mass with visible, defined borders, appearing at the edges of the lungs or a fissure dividing the lobes of the lungs. Similar hypoglycemic effects have been related to mesenchymal tumors.
